logo

For the Inventor, By the Inventor

Madison, WI, United States of America

Erika Hawkins

This inventor holds 19 USPTO granted patents and 1 published patent application and 4 EPO patents. Top assignee: Promega Corporation. Active years: 2006-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erika Hawkins. Retrieved from https://idiyas.com/inventor/erika-hawkins

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 

% Patents Active = 78.9

 

Average Co-Inventor Count = 6.3

ph-index = 9

Forward Citations = 233(Granted Patents)


Location History:

  • Pembroke, CA (2013 - 2014)
  • Madison, WI (US) (2006 - 2020)

Company Filing History:

goldMedal19 out of 417 
 
Promega Corporation
 patents

Years Active: 2006-2020

Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents
1. 10745365 - Luminogenic and fluorogenic compounds and methods to detect molecules or conditions (2020-08-18),
2. 10408819 - Luminescence-based methods and probes for measuring cytochrome P450 activity (2019-09-10),
3. 10077244 - Luminogenic and fluorogenic compounds and methods to detect molecules or conditions (2018-09-18),
4. 9631225 - Luciferase-based assays (2017-04-25),
5. 9574223 - Luminescence-based methods and probes for measuring cytochrome P450 activity (2017-02-21),
6. 8859220 - Luciferase-based assays (2014-10-14),
7. 8765969 - Luminescence-based methods and probes for measuring cytochrome P450 activity (2014-07-01),
8. 8603767 - Luciferase-based assays (2013-12-10),
9. 8476450 - Luminogenic and fluorogenic compounds and methods to detect molecules or conditions (2013-07-02),
10. 8361739 - Luciferase-based assays (2013-01-29),
11. 8106052 - Luminescence-based methods and probes for measuring cytochrome P450 activity (2012-01-31),
12. 7951550 - Luminogenic and fluorogenic compounds and methods to detect molecules or conditions (2011-05-31),
13. 7741067 - Luciferase-based assays (2010-06-22),
14. 7692022 - Luminescence-based methods and probes for measuring cytochrome P450 activity (2010-04-06),
15. 7537912 - Methods of measuring luminogenic activity with a protected coelenterazine (2009-05-26),

Title: Innovator Spotlight: Erika Hawkins and Her Contributions to Bioluminescence

Introduction: Erika Hawkins, an accomplished inventor based in Madison, Wisconsin, has made significant contributions to the field of bioluminescence through her 19 patents. Her innovative work focuses on developing novel compounds and methods for detecting molecules or conditions in various biological systems.

Latest Patents: Among her latest patents, Hawkins has introduced groundbreaking inventions such as luminogenic and fluorogenic compounds that enable the detection of specific molecules in samples. This method utilizes derivatives of luciferin or fluorophores, providing compounds and compositions essential for implementing these detection techniques. Additionally, her patent related to luminescence-based methods and probes for measuring cytochrome P450 activity reveals her focus on analyzing metabolic activity in cells and tissues. This invention presents one-step and two-step methods employing luminogenic molecules, including luciferins, that serve as substrates for bioluminescent enzymes like luciferase, ultimately enhancing the capacity for metabolic screening.

Career Highlights: Erika Hawkins's career has been marked by her tenure at Promega Corporation, a company known for its pioneering advancements in life sciences. Her work has not only fueled scientific inquiry but has also considerably impacted the fields of chemistry and biochemistry.

Collaborations: Throughout her career, Hawkins has collaborated with notable professionals, including Keith V Wood and James J Cali. These partnerships have likely contributed to her innovative approach and have strengthened her research endeavors.

Conclusion: Erika Hawkins stands out as a prominent figure in the realm of bioluminescence innovation. Her 19 patents reflect her commitment to advancing scientific knowledge and practical applications in the field. As she continues to push the boundaries of research, Hawkins's work will undoubtedly remain influential in the life sciences community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…